Patent Assignment
Reel/Frame 056586/0555
Assignment of Assignor's Interest
Recorded: 2021-06-18
Pages: 5
Assignor
WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
Executed: 2021-06-18
Assignee
CELLULAR BIOMEDICINE GROUP HK LIMITED
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
Covered Property
(1)
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 27, 2020
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.; WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
Reel/Frame 052761/0406 →
Assignment of Assignor's Interest
Jun 18, 2021
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056586/0533 →
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062100/0469 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →